Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
PUT
Cracker Barrel
CBRL
$1.31B
| $1.51M | ﹤0.01% |
10,300
-11,700
| -53% | -$1.75M |
|
3177
CALL
Interactive Brokers
IBKR
$41.4B
| $1.51M | ﹤0.01% |
109,600
+84,400
| +335% | +$1.28M |
|
3178
NovoCure
NVCR
$2.02B
| $1.51M | ﹤0.01% |
28,895
+20,189
| +232% | +$804K |
|
3179
PUT
Qiagen
QGEN
$8.93B
| $1.51M | ﹤0.01% |
+37,722
| New | +$1.51M |
|
3180
Energous
WATT
$82M
| $1.51M | ﹤0.01% |
249
+42
| +20% | +$326K |
|
|
PTLA
3181
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.51M | ﹤0.01% |
56,827
+39,050
| +220% | +$1.27M |
|
3182
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $1.51M | ﹤0.01% |
83,951
-40,830
| -33% | -$703K |
|
3183
ArcBest
ARCB
$3.28B
| $1.51M | ﹤0.01% |
31,055
-4,121
| -12% | -$193K |
|
3184
AXIS Capital
AXS
$7.3B
| $1.51M | ﹤0.01% |
26,118
-38,827
| -60% | -$2.2M |
|
|
FAZ
3185
PUT
Direxion Daily Financial Bear 3x ETF
FAZ
$84.2M
| $1.5M | ﹤0.01% |
387
-1
| -0.3% | -$3.88K |
|
3186
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$244M
| $1.5M | ﹤0.01% |
4,030
-1,200
| -23% | -$434K |
|
3187
Baytex Energy
BTE
$3B
| $1.5M | ﹤0.01% |
515,949
+472,180
| +1,079% | +$1.45M |
|
3188
Vera Bradley
VRA
$94.7M
| $1.5M | ﹤0.01% |
98,173
+17,584
| +22% | +$257K |
|
3189
Vanda Pharmaceuticals
VNDA
$304M
| $1.5M | ﹤0.01% |
65,232
+58,631
| +888% | +$1.2M |
|
|
GHL
3190
DELISTED
Greenhill & Co., Inc.
GHL
| $1.5M | ﹤0.01% |
56,824
+13,642
| +32% | +$405K |
|
|
ARA
3191
DELISTED
American Renal Associates Holdings, Inc
ARA
| $1.5M | ﹤0.01% |
69,154
+14,624
| +27% | +$277K |
|
3192
Radware
RDWR
$1.25B
| $1.5M | ﹤0.01% |
56,504
+37,992
| +205% | +$1.02M |
|
3193
PUT
Ross Stores
ROST
$78.6B
| $1.5M | ﹤0.01% |
15,100
-14,200
| -48% | -$1.3M |
|
3194
CALL
State Street SPDR S&P Bank ETF
KBE
$1.75B
| $1.49M | ﹤0.01% |
32,000
-2,700
| -8% | -$132K |
|
3195
Valvoline
VVV
$4.31B
| $1.49M | ﹤0.01% |
69,083
+57,883
| +517% | +$1.26M |
|
|
CADE
3196
DELISTED
Cadence Bancorporation
CADE
| $1.48M | ﹤0.01% |
56,743
-47
| -0.1% | -$1.32K |
|
3197
Winnebago Industries
WGO
$921M
| $1.48M | ﹤0.01% |
44,709
-21,239
| -32% | -$820K |
|
3198
Compass Minerals
CMP
$1.1B
| $1.48M | ﹤0.01% |
22,032
+18,784
| +578% | +$1.22M |
|
|
ADAM
3199
Adamas Trust
ADAM
$907M
| $1.48M | ﹤0.01% |
60,892
+26,870
| +79% | +$672K |
|
|
ONC
3200
CALL
BeOne Medicines Ltd
ONC
$40.3B
| $1.48M | ﹤0.01% |
+8,600
| New | +$1.45M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.